Next Article in Journal
The Brain Penetrating and Dual TORC1/TORC2 Inhibitor, RES529, Elicits Anti-Glioma Activity and Enhances the Therapeutic Effects of Anti-Angiogenetic Compounds in Preclinical Murine Models
Next Article in Special Issue
MicroRNA-Mediated Metabolic Reprograming in Renal Cancer
Previous Article in Journal
Exploiting ING2 Epigenetic Modulation as a Therapeutic Opportunity for Non-Small Cell Lung Cancer
Previous Article in Special Issue
Classic Chromophobe Renal Cell Carcinoma Incur a Larger Number of Chromosomal Losses Than Seen in the Eosinophilic Subtype
 
 
Article

Article Versions Notes

Cancers 2019, 11(10), 1602; https://doi.org/10.3390/cancers11101602
Action Date Notes Link
article xml file uploaded 21 October 2019 11:31 CEST Original file -
article xml uploaded. 21 October 2019 11:31 CEST Update https://www.mdpi.com/2072-6694/11/10/1602/xml
article pdf uploaded. 21 October 2019 11:31 CEST Version of Record https://www.mdpi.com/2072-6694/11/10/1602/pdf
article supplementary file uploaded. 21 October 2019 11:31 CEST - https://www.mdpi.com/2072-6694/11/10/1602#supplementary
article html file updated 21 October 2019 11:33 CEST Original file -
article html file updated 30 October 2019 21:32 CET Update -
article html file updated 14 February 2020 02:36 CET Update -
article html file updated 20 July 2022 01:14 CEST Update https://www.mdpi.com/2072-6694/11/10/1602/html
Back to TopTop